Gualou Xiebai Decoction prevents myocardial fibrosis by blocking TGF-beta/Smad signalling

Journal of Pharmacy and Pharmacology

Volumn 65, Issue 9, 2013, Pages 1373-1381

  Ding, Yong Fang ^a,b   Peng, Yun Ru ^b   Li, Juan ^b   Shen, Hong ^b   Shen, Ming Qin ^b   Fang, Tai Hui ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b Jiangsu Provincial Institute of Traditional Chinese Medicine   (China)

Author keywords

Gualou Xiebai Decoction (GXD); myocardial fibrosis; myocardial infarction; transforming growth factor 1

Indexed keywords

CAPTOPRIL; COLLAGEN TYPE 1; COLLAGEN TYPE 3; GUALOU XIEBAI; HERBACEOUS AGENT; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ALLIUM; ALLIUM MACROSTEMON; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DOWN REGULATION; GENE EXPRESSION; HEART INFARCTION; HEART LEFT VENTRICLE; HEART MUSCLE FIBROSIS; HEART WEIGHT; HISTOPATHOLOGY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TRICHOSANTHES; TRICHOSANTHES KIRILOWII; UPREGULATION; WESTERN BLOTTING;

EID: 84881464883     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12102     Document Type: Article

References (25)

1. Assayag P, et al. Compensated cardiac hypertrophy:arrhythmogenicity and the new myocardial phenotype, I: fibrosis. Cardiovasc Res 1997; 34: 439-444. (Pubitemid 27272662)
2. Yang HS, Liu PZ,. Influence to C-reactive protein, endothelin, blood rheology of coronary heart disease with syndrome of qi-stangnated blood stasis by gualou xiebai modified decection. Chin J Inf TCM 2004; 11: 1041-1042.
3. Chen B, et al. Protective effect of drug pair of Trichosanthes kirilowii and Allium macrostemon on the myocardial ischemia and reperfusion injury in rat. Chin J Integr Med 1997; 17: 1-2.
4. Zhang BT, et al. Influence of Gualou Xiebai Banxia Decoction on the endothelial vaso-active factors and myocardial pathomorphology of acute myocardial ischemia rats. Chin J Curr Tradit West Med 2005; 3: 193-195.
5. Ding YF, et al. Screening of active fraction on anti-myocardial ischemia from Gualou Xiebai Decoction. Jiangsu J Tradit Chin Med 2009; 41: 80-81 (in Chinese).
6. Ding YF, et al. Screening of active fraction on anti-myocardial ischemia from Gualou Xiebai Decoction(?). J Chin Med Mater 2010; 33: 1466-1469 (in Chinese).
7. Sun Y, Weber KT,. Animal models of cardiac fibrosis. Methods Mol Med 2005; 117: 273-290.
8. Gu WL, et al. Effect of Chinese herb medicine Radix Scrophulariae on ventricular remodeling. Pharmazie 2010; 65: 770-775.
9. Kuwahara F, et al. Transforming growth factor-β function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 2002; 106: 130-135. (Pubitemid 34747453)
10. Lijnen PJ, et al. Induction of cardiac fibrosis by transforming growth factor-beta (1). Mol Genet Metab 2000; 71: 418-435.
11. Leask A, Abraham DJTG,. F-β signaling and the fibrotic response. FASEB J 2004; 18: 816-817.
12. Horuguchi M, et al. Matrix control of transforming growth factor-β function. J Biochem 2012; 152: 321-329.
13. Rizik DG, et al. Promising though not yet proven: emerging strategies to promote myocardial salvage. Catheter Cardiovasc Interv 2006; 68: 596-606. (Pubitemid 44546054)
14. Feng Y, et al. Natural polypill Xuezhikang: its clinical benefit and potential multicomponent synergistic mechanisms of action in cardiovascular disease and other chronic conditions. J Alterna Complement Med 2012; 18: 318-328.
15. Hsieh SR, et al. Green tea extract protects rats against myocardial infarction associated with left anterior descending coronary artery ligation. Pflugers Archi 2009; 458: 631-642.
16. Massagué J,. TGF beta in cancer. Cell 2008; 134: 215-230.
17. Buxton IL, Duan D,. Cyclic GMP/protein kinase G phosphorylation of Smad3 blocks transforming growth factor-beta-induced nuclear Smad translocation: a key antifibrogenic mechanism of atrial natriuretic peptide. Circ Res 2008; 102: 151-153. (Pubitemid 351651117)
18. Park SH,. Fine tuning and cross-talking of TGF-beta signal by inhibitory Smads. J Biochem Mol Biol 2005; 38: 9-16.
19. Khan R, Sheppard R,. Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, vavular disease and arrhythmia. Immunology 2006; 118: 10-24.
20. Pohlers D, et al. TGF-β and fibrosis in different organs -molecular pathway imprints. Biochim Biophys Acta 2009; 1792: 746-756.
21. Wengrower D, et al. Prevention of fibrosis in experimental colitis by captopril: the role of tgf-beta1. Inflamm Bowel Dis 2004; 10: 536-546.
22. Zhang S, et al. Tribulosin protects rat hearts from ischemia/reperfusion injury. Acta Pharmacol Sin 2010; 31: 671-678.
23. Guo Y, et al. Remodeling after myocardial infarction in hyperlipidemic rats. Am J Chin Med 2007; 35: 309-316.
24. Kang LP, et al. Steroidal glycosides from the rhizomes of anemarrhena asphodeloides and their antiplatelet aggregation activity. Planta Med 2012; 78: 611-616.
25. Kaname N, et al. Effect of timosaponin E1 and E2 on superoxide generation induced by various stimuli in human neutrophils and on platelet aggregation in human blood. Clin Chim Acta 2000; 295: 129-140. (Pubitemid 30184804)